Minxuan Huang1, Kunihiro Matsushita2, Yingying Sang1, Shoshana H Ballew1, Brad C Astor3, Josef Coresh1. 1. Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 2. Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. Electronic address: kmatsush@jhsph.edu. 3. University of Wisconsin School of Medicine and Public Health, Madison, WI.
Abstract
BACKGROUND: Decreased kidney function and kidney damage may predate hypertension, but only a few studies have investigated both types of markers simultaneously, and these studies have obtained conflicting results. STUDY DESIGN: Cross-sectional for prevalent and prospective observational study for incident hypertension. SETTING & PARTICIPANTS: 9,593 participants from the ARIC (Atherosclerosis Risk in Communities) Study, aged 53-75 years in 1996-1998. PREDICTORS: Several markers of kidney function (estimated glomerular filtration rate using serum creatinine and/or cystatin C and 2 novel markers [β-trace protein and β2-microglobulin]) and 1 marker of kidney damage (urinary albumin-creatinine ratio [ACR]). Every kidney marker was categorized by its quintiles (top quintile as a reference for estimated glomerular filtration rates and bottom quintile for the rest). OUTCOMES: Prevalent and incident hypertension. MEASUREMENTS: Prevalence ratios and HRs of hypertension based on modified Poisson regression and Cox proportional hazards models, respectively. RESULTS: There were 4,378 participants (45.6%) with prevalent hypertension at baseline and 2,175 incident hypertension cases during a median follow-up of 9.8 years. Although all 5 kidney function markers were associated significantly with prevalent hypertension, prevalent hypertension was associated most notably with higher ACR (adjusted prevalence ratio, 1.60 [95% CI, 1.50-1.71] for the highest vs lowest ACR quintile). Similarly, ACR was associated consistently with incident hypertension in all models tested (adjusted HR, 1.28 [95% CI, 1.10-1.49] for top quintile), while kidney function markers demonstrated significant associations in some, but not all, models. Even mildly increased ACR (9.14-14.0mg/g) was associated significantly with incident hypertension. LIMITATIONS: Self-reported use of antihypertensive medication for defining incident hypertension, single assessment of kidney markers, and relatively narrow age range. CONCLUSIONS: Although all kidney markers were associated with prevalent hypertension, only elevated albuminuria was associated consistently with incident hypertension, suggesting that kidney damage is related more closely to hypertension than moderate reduction in overall kidney function.
BACKGROUND:Decreased kidney function and kidney damage may predate hypertension, but only a few studies have investigated both types of markers simultaneously, and these studies have obtained conflicting results. STUDY DESIGN: Cross-sectional for prevalent and prospective observational study for incident hypertension. SETTING & PARTICIPANTS: 9,593 participants from the ARIC (Atherosclerosis Risk in Communities) Study, aged 53-75 years in 1996-1998. PREDICTORS: Several markers of kidney function (estimated glomerular filtration rate using serum creatinine and/or cystatin C and 2 novel markers [β-trace protein and β2-microglobulin]) and 1 marker of kidney damage (urinary albumin-creatinine ratio [ACR]). Every kidney marker was categorized by its quintiles (top quintile as a reference for estimated glomerular filtration rates and bottom quintile for the rest). OUTCOMES: Prevalent and incident hypertension. MEASUREMENTS: Prevalence ratios and HRs of hypertension based on modified Poisson regression and Cox proportional hazards models, respectively. RESULTS: There were 4,378 participants (45.6%) with prevalent hypertension at baseline and 2,175 incident hypertension cases during a median follow-up of 9.8 years. Although all 5 kidney function markers were associated significantly with prevalent hypertension, prevalent hypertension was associated most notably with higher ACR (adjusted prevalence ratio, 1.60 [95% CI, 1.50-1.71] for the highest vs lowest ACR quintile). Similarly, ACR was associated consistently with incident hypertension in all models tested (adjusted HR, 1.28 [95% CI, 1.10-1.49] for top quintile), while kidney function markers demonstrated significant associations in some, but not all, models. Even mildly increased ACR (9.14-14.0mg/g) was associated significantly with incident hypertension. LIMITATIONS: Self-reported use of antihypertensive medication for defining incident hypertension, single assessment of kidney markers, and relatively narrow age range. CONCLUSIONS: Although all kidney markers were associated with prevalent hypertension, only elevated albuminuria was associated consistently with incident hypertension, suggesting that kidney damage is related more closely to hypertension than moderate reduction in overall kidney function.
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork Journal: N Engl J Med Date: 2006-03-14 Impact factor: 91.245
Authors: Joshua A Keefe; Shih-Jen Hwang; Tianxiao Huan; Michael Mendelson; Chen Yao; Paul Courchesne; Mohamed A Saleh; Meena S Madhur; Daniel Levy Journal: Hypertension Date: 2019-02 Impact factor: 10.190
Authors: Morgan E Grams; Casey M Rebholz; Yuan Chen; Andreea M Rawlings; Michelle M Estrella; Elizabeth Selvin; Lawrence J Appel; Adrienne Tin; Josef Coresh Journal: J Am Soc Nephrol Date: 2016-03-10 Impact factor: 10.121
Authors: Zhi Yu; Josef Coresh; Guanghao Qi; Morgan Grams; Eric Boerwinkle; Harold Snieder; Alexander Teumer; Cristian Pattaro; Anna Köttgen; Nilanjan Chatterjee; Adrienne Tin Journal: Kidney Int Date: 2020-05-23 Impact factor: 10.612
Authors: Tyler B Woodell; Jan M Hughes-Austin; Tiffany V Tran; Atul Malhotra; Joseph A Abdelmalek; Dena E Rifkin Journal: Blood Press Monit Date: 2016-04 Impact factor: 1.444
Authors: Simon B Ascher; Rebecca Scherzer; Carmen A Peralta; Phyllis C Tien; Carl Grunfeld; Michelle M Estrella; Alison Abraham; Deborah R Gustafson; Marek Nowicki; Anjali Sharma; Mardge H Cohen; Anthony W Butch; Mary A Young; Michael R Bennett; Michael G Shlipak Journal: Hypertension Date: 2016-12-19 Impact factor: 10.190
Authors: Teresa K Chen; Michelle M Estrella; Eric Vittinghoff; Feng Lin; Orlando M Gutierrez; Holly Kramer; Cora E Lewis; Jeffrey B Kopp; Norrina B Allen; Cheryl A Winkler; Kirsten B Bibbins-Domingo; Carmen A Peralta Journal: Kidney Int Date: 2017-05-23 Impact factor: 18.998
Authors: Hong Xu; Xiaoyan Huang; Ulf Risérus; Tommy Cederholm; Per Sjögren; Bengt Lindholm; Johan Ärnlöv; Juan Jesús Carrero Journal: Clin Kidney J Date: 2015-08-04